BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 26512438)

  • 1. The Morcellation Debate: The History and the Science.
    Adelman MR
    Clin Obstet Gynecol; 2015 Dec; 58(4):710-7. PubMed ID: 26512438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
    Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK
    Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No. 371-Morcellation During Gynaecologic Surgery: Its Uses, Complications, and Risks of Unsuspected Malignancy.
    Murji A; Scott S; Singh SS; Bougie O; Leyland N; Laberge PY; Vilos GA
    J Obstet Gynaecol Can; 2019 Jan; 41(1):116-126. PubMed ID: 30580824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACOG Committee Opinion No. 770: Uterine Morcellation for Presumed Leiomyomas.
    Obstet Gynecol; 2019 Mar; 133(3):e238-e248. PubMed ID: 30801477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.
    Lieng M; Berner E; Busund B
    J Minim Invasive Gynecol; 2015; 22(3):410-4. PubMed ID: 25460521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morcellation and myomas: Balancing decisions around minimally invasive treatments for fibroids.
    Siedhoff MT; Kim KH
    J Surg Oncol; 2015 Dec; 112(7):769-71. PubMed ID: 26768314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic Hysterectomy for Uterine Fibroids: Is it Safe?
    Hinchcliff EM; Cohen SL
    Clin Obstet Gynecol; 2016 Mar; 59(1):66-72. PubMed ID: 26670837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. U.S. Food and Drug Administration's Guidance Regarding Morcellation of Leiomyomas: Well-Intentioned, But Is It Harmful for Women?
    Parker WH; Kaunitz AM; Pritts EA; Olive DL; Chalas E; Clarke-Pearson DL; Berek JS;
    Obstet Gynecol; 2016 Jan; 127(1):18-22. PubMed ID: 26646134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-of-1 Policymaking--Tragedy, Trade-offs, and the Demise of Morcellation.
    Rosenbaum L
    N Engl J Med; 2016 Mar; 374(10):986-90. PubMed ID: 26962735
    [No Abstract]   [Full Text] [Related]  

  • 10. Iatrogenic parasitic leiomyoma and leiomyomatosis peritonealis disseminata following uterine morcellation.
    Lu B; Xu J; Pan Z
    J Obstet Gynaecol Res; 2016 Aug; 42(8):990-9. PubMed ID: 27125448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Electric Power Morcellation and Prevalence of Underlying Cancer in Women Who Undergo Myomectomy.
    Wright JD; Tergas AI; Cui R; Burke WM; Hou JY; Ananth CV; Chen L; Richards C; Neugut AI; Hershman DL
    JAMA Oncol; 2015 Apr; 1(1):69-77. PubMed ID: 26182307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the risks of electric uterine morcellation.
    Kho KA; Nezhat CH
    JAMA; 2014 Mar; 311(9):905-6. PubMed ID: 24504415
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of Morcellation Techniques at the Time of Laparoscopic Hysterectomy and Myomectomy.
    Meurs EAIM; Brito LG; Ajao MO; Goggins ER; Vitonis AF; Einarsson JI; Cohen SL
    J Minim Invasive Gynecol; 2017; 24(5):843-849. PubMed ID: 28483536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk, risk reduction and management of occult malignancy diagnosed after uterine morcellation: a commentary.
    Lynam S; Young L; Morozov V; Rao G; Roque DM
    Womens Health (Lond); 2015 Nov; 11(6):929-44. PubMed ID: 26673851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue Extraction Techniques for Leiomyomas and Uteri During Minimally Invasive Surgery.
    Siedhoff MT; Cohen SL
    Obstet Gynecol; 2017 Dec; 130(6):1251-1260. PubMed ID: 29112659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA warns against power morcellation for hysterectomy and fibroids.
    Wallis L
    Am J Nurs; 2014 Jul; 114(7):16. PubMed ID: 25742335
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing the risk of laparoscopic morcellation of occult uterine sarcomas during hysterectomy and myomectomy: Literature review and the ISGE recommendations.
    Sizzi O; Manganaro L; Rossetti A; Saldari M; Florio G; Loddo A; Zurawin R; van Herendael B; Djokovic D
    Eur J Obstet Gynecol Reprod Biol; 2018 Jan; 220():30-38. PubMed ID: 29149644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morcellation complications: From direct trauma to inoculation.
    Noel NL; Isaacson KB
    Best Pract Res Clin Obstet Gynaecol; 2016 Aug; 35():37-43. PubMed ID: 26879674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.
    Parker W; Pritts E; Olive D
    J Minim Invasive Gynecol; 2015; 22(4):696-7. PubMed ID: 25623370
    [No Abstract]   [Full Text] [Related]  

  • 20. Nonmalignant Sequelae of Unconfined Morcellation at Laparoscopic Hysterectomy or Myomectomy.
    Tulandi T; Leung A; Jan N
    J Minim Invasive Gynecol; 2016; 23(3):331-7. PubMed ID: 26802909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.